On March 17, 2025, CJ Biomaterials, a subsidiary of South Korea's CJ Group, officially signed a strategic cooperation agreement in Wuxi with Professor Ma Piming's research team from the School of Chemical and Materials Engineering at Jiangnan University (Research Center for Environmentally Friendly and Functional Composite Materials). Both parties will focus on...PHAJoint efforts in processing technology development.

Professor Ma Piming's research group at Jiangnan University has long focused on the research of bio-based and biodegradable polymer materials, achieving fruitful results in fields such as polymer modification processing and condensed matter structure regulation, completing more than 10 enterprise technical research projects. CJ Biomaterials, as a leading global enterprise in PHA industrialization, possesses a complete chain of technology reserves from research and development to application. This collaboration will integrate the research advantages of the university with the industrialization experience of the enterprise, focusing on breakthroughs in the pain points of PHA processing and accelerating the commercialization process of PHA application solutions.

In 2024, both parties will complete multiple performance verifications of PHA materials through short-term technical service cooperation, laying the foundation for deepening collaboration. In 2025, both parties plan to focus on innovative research and development of PHA, relying on the national research platform of Jiangnan University and the global technology network of CJ Biomaterials.

According to industry forecasts, the global PHA market is expected to exceed 10 billion USD by 2030. This collaboration not only strengthens CJ Biomaterials' technological advantage in the field of bi materials in China but also opens new pathways for the transformation of achievements at Jiangnan University, jointly promoting the industrial revolution of biodegradable materials as substitutes for traditional plastics.